临床结果-话题@MedSci

#临床结果#

135篇内容 | 3155人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1898785, encodeId=781d1898e8509, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=JACC：非综合征性胸主动脉夹层动脉瘤临床结果预测, objectType=article, longId=63162, objectId=f49863162b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f49863162b7, replyNumber=0, likeNumber=80, createdTime=2016-04-22, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f49863162b7, moduleTitle=JACC：非综合征性胸主动脉夹层动脉瘤临床结果预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f49863162b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898782, encodeId=5d791898e82b0, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=Lancet Dia& Endo：雷米普利不能改善肾移植受者的临床结果, objectType=article, longId=57707, objectId=e25f5e7076d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e25f5e7076d, replyNumber=0, likeNumber=114, createdTime=2016-09-06, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e25f5e7076d, moduleTitle=Lancet Dia& Endo：雷米普利不能改善肾移植受者的临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e25f5e7076d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898784, encodeId=4ce51898e8414, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=JACC：环孢素A（CsA）不能改善心肌梗死（MI）再灌注患者的临床结果, objectType=article, longId=62638, objectId=3e7d62638f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e7d62638f9, replyNumber=0, likeNumber=72, createdTime=2016-09-06, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e7d62638f9, moduleTitle=JACC：环孢素A（CsA）不能改善心肌梗死（MI）再灌注患者的临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e7d62638f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898783, encodeId=fd541898e83c0, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=JCO：用药剂量改变可以改善AML亚型的临床结果, objectType=article, longId=58935, objectId=dd9b58935c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd9b58935c5, replyNumber=0, likeNumber=76, createdTime=2016-10-29, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd9b58935c5, moduleTitle=JCO：用药剂量改变可以改善AML亚型的临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd9b58935c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898780, encodeId=1da11898e80e8, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=Lancet Oncol：PALB2突变的乳腺癌临床结果, objectType=article, longId=50470, objectId=96c1504e00b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96c1504e00b, replyNumber=0, likeNumber=75, createdTime=2015-08-16, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96c1504e00b, moduleTitle=Lancet Oncol：PALB2突变的乳腺癌临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96c1504e00b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898781, encodeId=0b481898e81f4, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=Teva迟发型运动障碍药Deutetrabenazine临床结果可喜，系该领域首例疗法, objectType=article, longId=52401, objectId=2e3152401d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e3152401d2, replyNumber=0, likeNumber=80, createdTime=2016-05-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e3152401d2, moduleTitle=Teva迟发型运动障碍药Deutetrabenazine临床结果可喜，系该领域首例疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e3152401d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898779, encodeId=de861898e79ff, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=Puma生物科技宣布neratinib“积极”临床结果, objectType=article, longId=42661, objectId=a7b64266110, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7b64266110, replyNumber=0, likeNumber=100, createdTime=2015-07-28, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7b64266110, moduleTitle=Puma生物科技宣布neratinib“积极”临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7b64266110)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898778, encodeId=09271898e7849, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=ASCO 2014：克唑替尼一线治疗晚期ALK阳性非鳞NSCLCIII期临床结果, objectType=article, longId=35008, objectId=5921350089f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5921350089f, replyNumber=0, likeNumber=80, createdTime=2014-07-16, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5921350089f, moduleTitle=ASCO 2014：克唑替尼一线治疗晚期ALK阳性非鳞NSCLCIII期临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5921350089f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898777, encodeId=80281898e77d5, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=La Jolla治疗慢性肾病药物二期临床结果良好, objectType=article, longId=31833, objectId=301e31833ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=301e31833ed, replyNumber=0, likeNumber=88, createdTime=2014-10-06, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=301e31833ed, moduleTitle=La Jolla治疗慢性肾病药物二期临床结果良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=301e31833ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898775, encodeId=5d801898e75a1, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=Akebia公司AKB-6548治疗慢性肾病 II阶段临床结果公布, objectType=article, longId=5416, objectId=815a541662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=815a541662, replyNumber=0, likeNumber=98, createdTime=2012-08-05, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=815a541662, moduleTitle=Akebia公司AKB-6548治疗慢性肾病 II阶段临床结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=815a541662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898776, encodeId=c8531898e761a, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=Aeterna公司公布成人生长激素缺乏症治疗药物AEZS-130 3期临床结果, objectType=article, longId=7442, objectId=2e04e44244, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e04e44244, replyNumber=0, likeNumber=71, createdTime=2012-09-18, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e04e44244, moduleTitle=Aeterna公司公布成人生长激素缺乏症治疗药物AEZS-130 3期临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e04e44244)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898772, encodeId=a0471898e723d, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=沈卫峰公布SERY I 2年临床结果, objectType=article, longId=4413, objectId=40564413a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40564413a8, replyNumber=0, likeNumber=112, createdTime=2013-02-23, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40564413a8, moduleTitle=沈卫峰公布SERY I 2年临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40564413a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898774, encodeId=911b1898e7404, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=葛均波院士公布FOCUS研究 2年临床结果, objectType=article, longId=4415, objectId=4ea94415a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ea94415a1, replyNumber=0, likeNumber=89, createdTime=2012-04-23, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ea94415a1, moduleTitle=葛均波院士公布FOCUS研究 2年临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ea94415a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898773, encodeId=d3441898e73a1, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=杨跃进公布NOYA I 2年临床结果, objectType=article, longId=4414, objectId=f875441493, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f875441493, replyNumber=0, likeNumber=83, createdTime=2012-04-06, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f875441493, moduleTitle=杨跃进公布NOYA I 2年临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f875441493)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898771, encodeId=210c1898e7148, content=<a href='/topic/show?id=729322969b9' target=_blank style='color:#2F92EE;'>#临床结果#</a>, objectTitle=PCI术前常规置入IABP能改善高危患者的临床结果吗？——BCIS-1研究解读, objectType=article, longId=3603, objectId=edac36034d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edac36034d, replyNumber=0, likeNumber=71, createdTime=2012-03-26, rootId=0, userName=oliver169, userId=4fd6156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edac36034d, moduleTitle=PCI术前常规置入IABP能改善高危患者的临床结果吗？——BCIS-1研究解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edac36034d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

临床结果

2020-05-29

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

JACC：非综合征性胸主动脉夹层动脉瘤临床结果预测

2016-04-22

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

Lancet Dia& Endo：雷米普利不能改善肾移植受者的临床结果

2016-09-06

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

JACC：环孢素A（CsA）不能改善心肌梗死（MI）再灌注患者的临床结果

2016-09-06

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

JCO：用药剂量改变可以改善AML亚型的临床结果

2016-10-29

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

Lancet Oncol：PALB2突变的乳腺癌临床结果

2015-08-16

仁者大医 (审核中...)

前往app查看评论内容

#临床结果#

Teva迟发型运动障碍药Deutetrabenazine临床结果可喜，系该领域首例疗法

2016-05-11

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

Puma生物科技宣布neratinib“积极”临床结果

2015-07-28

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

ASCO 2014：克唑替尼一线治疗晚期ALK阳性非鳞NSCLCIII期临床结果

2014-07-16

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

La Jolla治疗慢性肾病药物二期临床结果良好

2014-10-06

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

Akebia公司AKB-6548治疗慢性肾病 II阶段临床结果公布

2012-08-05

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

Aeterna公司公布成人生长激素缺乏症治疗药物AEZS-130 3期临床结果

2012-09-18

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

沈卫峰公布SERY I 2年临床结果

2013-02-23

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

葛均波院士公布FOCUS研究 2年临床结果

2012-04-23

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

杨跃进公布NOYA I 2年临床结果

2012-04-06

oliver169 (审核中...)

前往app查看评论内容

#临床结果#

PCI术前常规置入IABP能改善高危患者的临床结果吗？——BCIS-1研究解读

2012-03-26

科室
- - 订阅+
  - 更多科室
工具
服务